268 related articles for article (PubMed ID: 29049200)
21. Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity.
Ristić GG; Subota V; Lepić T; Stanisavljević D; Glišić B; Ristić AD; Petronijević M; Stefanović DZ
PLoS One; 2015; 10(8):e0130462. PubMed ID: 26247590
[TBL] [Abstract][Full Text] [Related]
22. [Cardiovascular diseases in rheumatoid arthritis].
Popkova TV; Khelkovskaia AN; Mach ES; Aleksandrova EN; Novikov AA; Novikova DS; Nasonov EL
Ter Arkh; 2007; 79(5):9-14. PubMed ID: 17672067
[TBL] [Abstract][Full Text] [Related]
23. The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.
Södergren A; Karp K; Bengtsson C; Möller B; Rantapää-Dahlqvist S; Wållberg-Jonsson S
J Rheumatol; 2015 Jun; 42(6):935-42. PubMed ID: 25877503
[TBL] [Abstract][Full Text] [Related]
24. Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.
Spinelli FR; Pecani A; Ciciarello F; Colasanti T; Di Franco M; Miranda F; Conti F; Valesini G; Alessandri C
BMC Musculoskelet Disord; 2017 May; 18(1):214. PubMed ID: 28545441
[TBL] [Abstract][Full Text] [Related]
25. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
[TBL] [Abstract][Full Text] [Related]
26. Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population.
Selmi C; De Santis M; Battezzati PM; Generali E; Lari SA; Ceribelli A; Isailovic N; Zermiani P; Neidhöfer S; Matthias T; Scirè CA; Baldassarre D; Zuin M
Int J Cardiol; 2020 Feb; 300():209-213. PubMed ID: 31757648
[TBL] [Abstract][Full Text] [Related]
27. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
[TBL] [Abstract][Full Text] [Related]
28. Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices.
Ozen G; Inanc N; Unal AU; Korkmaz F; Sunbul M; Ozmen M; Akar S; Deniz R; Donmez S; Pamuk ON; Atagunduz P; Tigen K; Direskeneli H
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1538-46. PubMed ID: 26866424
[TBL] [Abstract][Full Text] [Related]
29. Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population.
Gómez-Bañuelos E; Martín-Márquez BT; Martínez-García EA; Figueroa-Sanchez M; Nuñez-Atahualpa L; Rocha-Muñoz AD; Sánchez-Hernández PE; Navarro-Hernandez RE; Madrigal-Ruiz PM; Saldaña-Millan AA; Duran-Barragan S; Gonzalez-Lopez L; Gamez-Nava JI; Vázquez-Del Mercado M
Biomed Res Int; 2014; 2014():736786. PubMed ID: 25006585
[TBL] [Abstract][Full Text] [Related]
30. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.
De Socio GV; Martinelli C; Ricci E; Orofino G; Valsecchi L; Vitiello P; Martinelli L; Quirino T; Maggi P; Bonfanti P;
Int J STD AIDS; 2010 Apr; 21(4):267-72. PubMed ID: 20378899
[TBL] [Abstract][Full Text] [Related]
31. Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis.
Montes A; Corrales A; Calaza M; Lopez-Mejias R; Parra JA; González-Gay MA; González A
Arthritis Rheumatol; 2015 Nov; 67(11):2861-5. PubMed ID: 26246227
[TBL] [Abstract][Full Text] [Related]
32. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group.
Cacciapaglia F; Spinelli FR; Piga M; Erre GL; Sakellariou G; Manfredi A; Viapiana O; Fornaro M; Colella S; Floris A; Mangoni AA; Castagna F; Vacchi C; Orsolini G; Bugatti S; Cafaro G; Cauli A; Gremese E; Atzeni F; Bartoloni E
Eur J Intern Med; 2022 Feb; 96():60-65. PubMed ID: 34657778
[TBL] [Abstract][Full Text] [Related]
33. Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
Quevedo-Abeledo JC; Rúa-Figueroa Í; Sánchez-Pérez H; Naranjo A; de Armas-Rillo L; Tejera-Segura B; Lopez-Mejías R; González-Gay MÁ; Ferraz-Amaro I
Clin Exp Rheumatol; 2020; 38(5):917-924. PubMed ID: 31969232
[TBL] [Abstract][Full Text] [Related]
34. Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis.
Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Vera-Pineda R; Garcia-Colunga JI; Arvizu-Rivera RI; Martinez-Moreno A; Villarreal-Perez JZ; Elizondo-Riojas G; Garza Elizondo MA
Clin Rheumatol; 2016 Nov; 35(11):2823-2827. PubMed ID: 27222044
[TBL] [Abstract][Full Text] [Related]
35. Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
Crowson CS; Rollefstad S; Ikdahl E; Kitas GD; van Riel PLCM; Gabriel SE; Matteson EL; Kvien TK; Douglas K; Sandoo A; Arts E; Wållberg-Jonsson S; Innala L; Karpouzas G; Dessein PH; Tsang L; El-Gabalawy H; Hitchon C; Ramos VP; Yáñez IC; Sfikakis PP; Zampeli E; Gonzalez-Gay MA; Corrales A; Laar MV; Vonkeman HE; Meek I; Semb AG;
Ann Rheum Dis; 2018 Jan; 77(1):48-54. PubMed ID: 28877868
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular Disease Risk Factors in Ghana during the Rural-to-Urban Transition: A Cross-Sectional Study.
Kodaman N; Aldrich MC; Sobota R; Asselbergs FW; Poku KA; Brown NJ; Moore JH; Williams SM
PLoS One; 2016; 11(10):e0162753. PubMed ID: 27732601
[TBL] [Abstract][Full Text] [Related]
37. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
38. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
[TBL] [Abstract][Full Text] [Related]
39. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.
Crowson CS; Myasoedova E; Davis JM; Matteson EL; Roger VL; Therneau TM; Fitz-Gibbon P; Rodeheffer RJ; Gabriel SE
J Rheumatol; 2011 Jan; 38(1):29-35. PubMed ID: 20952464
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
